Logo wahanariau.com
  2. New jersey

New jersey

Index
Globenewswire

Verisk Wildfire Model is the First Catastrophe Model Under Review for Insurance Ratemaking in the State of California

Jumat, 03 Januari 2025 - 04:19:18 Wib
Globenewswire

New BASF VOC2.0™ Catalyst Technology Now Available in the VOZC™ Converter on Airbus A320 Fleet

Kamis, 19 Desember 2024 - 01:27:48 Wib
Globenewswire

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Selasa, 17 Desember 2024 - 20:30:00 Wib
Globenewswire

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

Rabu, 11 Desember 2024 - 20:07:02 Wib
Globenewswire

BASF Environmental Catalyst and Metal Solutions meraih Penghargaan Paten Edison 2024

Sabtu, 23 November 2024 - 22:00:00 Wib
Globenewswire

BASF Environmental Catalyst and Metal Solutions wins 2024 Edison Patent Award

Jumat, 22 November 2024 - 22:00:00 Wib
Globenewswire

Horizon Group USA Accelerates Global Growth Strategy with Expanded Leadership

Rabu, 13 November 2024 - 20:30:00 Wib
Globenewswire

Synchronoss Memperpanjang Kemitraan dengan Operator Utama Prancis

Rabu, 13 November 2024 - 04:28:55 Wib
Globenewswire

Synchronoss Renews Partnership with Major French Operator

Selasa, 12 November 2024 - 20:30:00 Wib
Globenewswire

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition

Sabtu, 02 November 2024 - 03:59:12 Wib
Globenewswire

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as Well as

Sabtu, 02 November 2024 - 03:58:04 Wib
Globenewswire

ORBCOMM Launches First Native Satellite Tracker for Advanced OGx Network

Rabu, 23 Oktober 2024 - 21:30:00 Wib
Globenewswire

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)

Selasa, 22 Oktober 2024 - 18:30:00 Wib
Globenewswire

Orbcomm Joins Move to -15°C Coalition to Promote Cold Chain Sustainability

Selasa, 08 Oktober 2024 - 16:30:00 Wib
Globenewswire

Verisk Welcomes Greg Hendrick to Its Board of Directors

Selasa, 02 April 2024 - 06:25:39 Wib